MRI assessment of ablation-induced scarring in atrial fibrillation: Analysis from the DECAAF study

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 5, 2015, Pages 473-480

  Akoum, Nazem ^a   Wilber, David ^c   Hindricks, Gerhard ^d   Jais, Pierre ^e   Cates, Josh ^b   Marchlinski, Francis ^f   Kholmovski, Eugene ^b   Burgon, Nathan ^b   Hu, Nan ^b   Mont, Lluis ^g   Deneke, Thomas ^h   Duytschaever, Mattias ⁱ   Neumann, Thomas ^j   Mansour, Moussa ^k   Mahnkopf, Christian ^l   Hutchinson, Mathew ^e   Herweg, Bengt ^m   Daoud, Emile ⁿ   Wissner, Erik ^o   Brachmann, Johannes ^l   Marrouche, Nassir F ^b   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF BARCELONA   (Spain)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

^j Kerckhoff Heart Center   (Germany)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l KLINIKUM COBURG   (Germany)

^m UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁿ OHIO STATE UNIVERSITY   (United States)

^o DEPARTMENT OF CARDIOLOGY   (Germany)

more..

Author keywords

atrial fibrillation; atrial scar; cardiac MRI; catheter ablation; pulmonary vein isolation

Indexed keywords

ARTICLE; ATRIAL FIBRILLATION; ATRIAL FIBROSIS; CATHETER ABLATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; SCAR FORMATION; THREE DIMENSIONAL IMAGING; ADVERSE EFFECTS; AGED; AUSTRALIA; CLINICAL TRIAL; EUROPE; FIBROSIS; HEART ATRIUM; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCAR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; ATRIAL FIBRILLATION; AUSTRALIA; CATHETER ABLATION; CICATRIX; EUROPE; FEMALE; FIBROSIS; HEART ATRIA; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84929261308     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12650     Document Type: Article

References (23)

1. Calkins H, Brugada J, Packer DL, Cappato R, Chen S-A, Crijns HJG, Damiano RJ, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Heart Rhythm 2007; 4: 816-861.
2. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J,: Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
3. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, Veerareddy S, Pelosi F, Morady F,: Catheter ablation for paroxysmal atrial fibrillation. Circulation 2003; 108: 2355-2360.
4. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A,: Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005; 45: 285-292.
5. Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, Vohra JK, Kumar S, Kalman JM,: Pulmonary vein antral isolation for paroxysmal atrial fibrillation: Results from long-term follow-up. J Cardiovasc Electrophysiol 2011; 22: 137-141.
6. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I,: Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation/clinical perspective. Circulation Arrhythm Electrophysiol 2009; 2: 349-361.
7. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM,: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
8. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ,: Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: Initial experience. Radiology 2007; 243: 690-695.
9. McGann CJ, Kholmovski EG, Oakes RS, Blauer JJE, Daccarett M, Segerson N, Airey KJ, Akoum N, Fish E, Badger TJ, DiBella EVR, Parker D, MacLeod RS, Marrouche NF,: New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 2008; 52: 1263-1271.
10. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJE, Rao SN, DiBella EVR, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF,: Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758-1767.
11. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N,: Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: A DE-MRI guided approach. J Cardiovasc Electrophysiol 2011; 22: 16-22.
12. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS, Marrouche NF,: Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 2014; 7: 23-30.
13. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J,: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study. JAMA 2014; 311: 498-506.
14. Johnson H, Zhao Y,: Brainsdemonwarp: An application to perform demons registration. Insight J 2009.
15. Kowalski M, Grimes MM, Perez FJ, Kenigsberg DN, Koneru J, Kasirajan V, Wood MA, Ellenbogen KA,: Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol 2012; 59: 930-938.
16. Ranjan R, Kato R, Zviman MM, Dickfeld TM, Roguin A, Berger RD, Tomaselli GF, Halperin HR,: Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI/clinical perspective. Circ Arrhythm Electrophysiol 2011; 4: 279-286.
17. Dukkipati SR, Neuzil P, Kautzner J, Petru J, Wichterle D, Skoda J, Cihak R, Peichl P, Dello Russo A, Pelargonio G, Tondo C, Natale A, Reddy VY,: The durability of pulmonary vein isolation using the visually guided laser balloon catheter: Multicenter results of pulmonary vein remapping studies. Heart Rhythm 2012; 9: 919-925.
18. Badger TJ, Daccarett M, Akoum NW, Adjei-Poku YA, Burgon NS, Haslam TS, Kalvaitis S, Kuppahally S, Vergara G, McMullen L, Anderson PA, Kholmovski E, MacLeod RS, Marrouche NF,: Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: Lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol 2010; 3: 249-259.
19. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS, Marrouche NF,: Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 2014; 7: 23-30.
20. Nattel S, Burstein B, Dobrev D,: Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circ Arrhythm Electrophysiol 2008; 1: 62-73.
21. Allessie M, Ausma J, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Research 2002; 54: 230-246.
22. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T,: A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044-2053.
23. Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM,: Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: On-treatment analysis of the confirm trial (conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol 2013; 62: 138-147.